Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing compound doai
Patent
1996-06-20
1997-12-02
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing compound doai
514470, 514740, 514171, 514179, 514312, 514882, 514929, A61K 3104
Patent
active
056936761
ABSTRACT:
A pharmaceutical composition contains a nitric oxide donor and advantageously an optional corticosteroid and/or topical anesthetic. The composition is useful in a method for treating anal disorders such as anal fissure, anal ulcer, hemorrhoidal disease, levator spasm, and so forth, by topical application to or proximate the affected area.
REFERENCES:
patent: 814408 (1906-03-01), Steele
patent: 2840080 (1958-06-01), Clark
patent: 4118480 (1978-10-01), Williams
patent: 4292299 (1981-09-01), Suzuki et al.
patent: 5059603 (1991-10-01), Rubin
patent: 5183663 (1993-02-01), Greiner
Rattan, et al., "Nitric Oxide Pathway in Rectoanal Inhibitory Reflex of Opossum Internal Anal Sphincter", No As a Gut Smooth Muscle-Inhibitory Mediator, 1992.
Rattan, et al., "Role of Nitric Oxide as a Mediatory of Internal Anal Sphincter Relaxation", Nitric Oxide As Gut Smooth Muscle Inhibitory Mediator, pp. G107-G112, 1991.
O'Kelly, et al., "Nerve Mediatd Relaxation of the Human Internal Anal Sphincter: The Role of Nitric Oxide", Gut, pp. 689-693, 1993.
Chakder, et al., "Release of Nitric Oxide by Activation of Nonadrenergic Noncholinergic Neurons of Internal Anal Sphincter", No Release By Nanc Neural Stimulation and VIP, pp. G7-G12, 1992.
Loder, et al., "Reversible Chemical Sphincterotomy by Local Application of Glyceryl Trinitrate", British Journal of Surgery, pp. 1386-1389, 1994.
Shafik, "Role of warm-water bath in anorectal; conditions: The `thermosphincteric reflex,`" J. Clin. Gastroenterol., 16:304-308, 1993.
Gillespie et al., "Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle,"Br. J. Pharmacol., 95:1151-1156, 1988.
Ignarro et al., "Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle,"Biochem. Biophys. Res. Commun., 170:843-850, 1990.
Bult et al., "Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter,"Nature, 345:346-347, 1990.
Feelisch et al., "Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase,"Eur. J. Pharmacol., 139:19-30, 1987.
Fung et al., "Biochemical mechanism of organic nitrate action," Am. J. Cardiol., 70:4B-10B, 1992.
Huff et al., (Eds.), "Physicians' Desk Reference," 41st Edition, Medical Economics Company, Oradell, N.J., 1987, at pp. 780, 1176-1178, 1533 and 1984-85.
Loder et al. "AGA Abstracts" Gastroenterology, vol. 104 No. 4, 1993.
Budavari et al. (Eds.), " The Merck Index,"11th Edition, Merck & Co., Rahway, N.J., 1989, pp. 198 and 821 (isopropyl nitrate).
Guillemot, et al., "Action of In Situ Nitroglycerin on Upper Anal Canal Pressure of Patients with Terminal Constipation" Dis Colon Rectum, Apr. 1993.
Neptune Pharmaceutical Corporation
Rollins John W.
LandOfFree
Nitric oxide donor composition and method for treatment of anal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitric oxide donor composition and method for treatment of anal , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide donor composition and method for treatment of anal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-801782